Your Advocates Ltd’s Organon & Co OGN Stock Holding History

Your Advocates Ltd’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24	Closed	-$499	–	335
2023 Q2	$499	Buy	+24	New	+$522	﹤0.01%	254

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

Your Advocates Ltd's OGN Position: Q3 2023 in Review

Your Advocates Ltd sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 24 shares — an estimated $499 sold.

Your Advocates Ltd first reported a position in OGN in Q2 2023 and held it in 1 quarter. The position peaked at $499 in Q2 2023. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

Your Advocates Ltd reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
Your Advocates Ltd sold 24 Organon & Co shares in Q3 2023, an estimated $499.
Your Advocates Ltd first reported a position in Organon & Co in Q2 2023 and held it in 1 quarter.
Your Advocates Ltd's Organon & Co position peaked at $499 in Q2 2023.
730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Your Advocates Ltd's 13F filing for Q3 2023, filed 2 Nov 2023.